Advancing Biologics & Tides R&D

Experience groundbreaking in-person events, engaging online activities, and cutting-edge digital services that unite influential and passionate leaders with scientific experts, collectively shaping the future of biologics & tides.

In-Person & Online Events

Collaborate & Partner for a Better Future

Explore Biologics & Tides

Unite with the biologics & tides industry's foremost leaders and scientific experts through our year-round global activities. Immerse yourself in cutting-edge scientific content - from online Monthly Science Exchanges, best practice Online Symposiums to eBooks and landscape reports providing a unique perspective on the latest R&D trends and challenges.

Resources & Announcements


20/08/24 - The two organisations will work side by side on up to six programmes which will develop new cancer drug candidates using AI.
06/08/24 - The novel peptide synthesis protocol allows the synthesis of multiple peptide fragments on a single bead.
15/07/24 - The fast track designation means that the clinical development and regulatory milestones of the drug candidate are likely to progress much faster.
03/07/24 - CureVac will continue to build its R&D pipeline while allowing GSK to develop and commercialise a handful of its prophylactic mRNA vaccines.
30/06/24 - Kurt Wüthrich, joint winner of the 2002 Nobel Prize for Chemistry, contributed to the use of NMR to discover the 3D structure of proteins using sequential assignment and mathematical techniques.
23/06/24 - 2002's Nobel Prize for Chemistry recognised the translation of mass spectrometry to large molecules which has been instrumental in unlocking the proteome toward new therapies.
12/06/24 - A concise report featuring insights from the prominent thought leaders of Biologics 2024

Online Activities


17/09/24, 13.00 BST | Science Exchange

Oral Delivery of Peptide Therapeutics

Presented by Joël Richards, Chief Development Officer, Enterome and Panellists Hans Melo, Co-Founder & Chief Executive Officer, Menten AI & Jutta Eichler, Professor of Medicinal Chemistry, University of Erlangen-Nurnberg
19/09/24, 5pm BST | Sponsor Webinar

Unchained Labs - Fast-Track Formulation with Biologics Screening in a Snap

Planned for October 2024 | Science Exchange

Challenges & Opportunities In Biologics Characterisation & Analysis

02/10/24 | Sponsor Webinar

Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes

Oxford Global PLUS Pass

Introducing the PLUS Pass – your exclusive 12-month, all-access gateway to over 40 prestigious events hosted annually across the UK, Europe, and the US.

Tailored for experts, thought-leaders, and scientists from global pharma & biotech, the PLUS Pass not only grants you entry to our curated event experiences but also offers boundless knowledge sharing through our robust PLUS Platform. Immerse yourself in a wealth of on-demand event recordings, content articles, and industry news, while engaging in thought-provoking exclusive webinars and stimulating group discussions each month.

Oxford Global PLUS

Services

Driving impact, awareness, and business generation

Our extensive and engaged community extends across large, mid-size and innovative start-ups within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

  • In-Person Services

    At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.
  • Digital Marketing Services

    Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics & tides